The Effect Of Anaerobic Exercise On Bone Morphogenetic Protein 9

Sponsor
Ege University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05117437
Collaborator
(none)
81
1
11.9
6.8

Study Details

Study Description

Brief Summary

Bone morphogenetic protein (BMP) 9 from the BMP family has an important role in the remodeling of bone and cartilage. Due to these features, BMP9 can play an important role in especially anaerobic exercise training adaptations. However, the role of anaerobic exercise in these effects is still unclear. The aim of this study is to investigate the role of BMP9 on the effects of acute and chronic anaerobic exercise on bone metabolism markers. Postprandial venous blood samples were taken pre- and post- acute YOYO intermittent recovery test (level 1) in 40 trained male athletes aged 18-35 who did anaerobic sports (such as basketball, volleyball and handball) and 41 sedentary volunteers aged 18-35. Serum BMP9, as markers of bone formation and resorption; alkaline phosphatase (ALP), C-terminal telopeptide of type 1 collagen (CTX1), cartilage oligomeric matrix protein (COMP) and calcium levels were determined. The data to be obtained as a result of our study can give information about the relationship between the skeletal and bone health of the athletes and anaerobic exercise.

Condition or Disease Intervention/Treatment Phase
  • Other: Physiological test
  • Other: Physical test
  • Other: Biochemical tests

Study Design

Study Type:
Observational
Actual Enrollment :
81 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
The Effect Of Anaerobic Exercise On Bone Morphogenetic Protein 9
Actual Study Start Date :
Dec 3, 2020
Actual Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Athletic group

Healthy male athletes who have been doing regular anaerobic sports (such as basketball, volleyball and handball) for at least 3 months

Other: Physiological test
This test was conducted to determine the endurance levels of the participants.
Other Names:
  • YOYO intermittent recovery test (level 1)
  • Other: Physical test
    Height, weight, and BMI were determined

    Other: Biochemical tests
    BMP9, CTX1, COMP, oxLDL protein levels, ALP, GGT, TAS, TOS, OSI, NO, calcium, T-C, LDL-C, Triglyceride, HDL-C, glucose, CRP, AST, ALT, erythrocyte, mean erythrocyte volume (MCV), hematocrit, leukocyte, thrombocyte levels were determined from blood samples.

    Control group

    Healthy sedentary (not doing regular sports for at least 3 months) men with age and physical characteristics similar to the athlete group

    Other: Physiological test
    This test was conducted to determine the endurance levels of the participants.
    Other Names:
  • YOYO intermittent recovery test (level 1)
  • Other: Physical test
    Height, weight, and BMI were determined

    Other: Biochemical tests
    BMP9, CTX1, COMP, oxLDL protein levels, ALP, GGT, TAS, TOS, OSI, NO, calcium, T-C, LDL-C, Triglyceride, HDL-C, glucose, CRP, AST, ALT, erythrocyte, mean erythrocyte volume (MCV), hematocrit, leukocyte, thrombocyte levels were determined from blood samples.

    Outcome Measures

    Primary Outcome Measures

    1. Change from serum BMP9 levels at pre- and post- YOYO intermittent test [between 40-50 minutes]

      Postprandial venous blood samples were obtained before and after acute YOYO IR test (level 1). The YOYO test lasted 10-20 minutes depending on the ability level of the participants. A blood sample was taken 15 minutes before and 15 minutes after the YOYO test. From these blood samples, serum Bone morphogenetic protein 9 (BMP9) was determined.

    2. Change from serum CTX1 levels at pre- and post- YOYO intermittent test [between 40-50 minutes]

      Postprandial venous blood samples were obtained before and after acute YOYO IR test (level 1). The YOYO test lasted 10-20 minutes depending on the ability level of the participants. A blood sample was taken 15 minutes before and 15 minutes after the YOYO test. From these blood samples, serum C-terminal telopeptide of Type 1 collagen (CTX1) was determined.

    3. Change from serum COMP levels at pre- and post- YOYO intermittent test [between 40-50 minutes]

      Postprandial venous blood samples were obtained before and after acute YOYO IR test (level 1). The YOYO test lasted 10-20 minutes depending on the ability level of the participants. A blood sample was taken 15 minutes before and 15 minutes after the YOYO test. From these blood samples, serum cartilage oligomeric matrix protein (COMP) was determined.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • being male

    • having a body mass index of less than 30 being

    Exclusion Criteria:
    • to have some disease or disability

    • to regularly use cigarettes and alcohol

    • to use any medication or antioxidant substance

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ege University Faculty of Sport Sciences İzmir Turkey 35040

    Sponsors and Collaborators

    • Ege University

    Investigators

    • Study Director: Faruk Turgay, Ege University Faculty of Sport Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Faruk Turgay, Associate Professor, Ege University
    ClinicalTrials.gov Identifier:
    NCT05117437
    Other Study ID Numbers:
    • TDK-2020-22186
    • TDK-2020-22186
    First Posted:
    Nov 11, 2021
    Last Update Posted:
    Nov 11, 2021
    Last Verified:
    Nov 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Faruk Turgay, Associate Professor, Ege University

    Study Results

    No Results Posted as of Nov 11, 2021